英斯派尔医疗

最新新闻

• 评级变动
  Freedom Capital Markets Initiates Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $62
  \u5e02\u573a\u8d44\u8baf · 2026/7/2
• 评级变动
  Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• RBC Capital Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Raises Target Price to $75
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• RBC Capital Initiates Inspire Medical Systems(INSP.US) With Hold Rating, Announces Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  KeyBanc Maintains Inspire Medical Systems(INSP.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  J.P. Morgan Remains a Hold on Inspire Medical Systems (INSP)
  TipRanks · 2026/8/4
• 评级变动
  Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/9/14
• 公司公告
  Puyuan Information: Independent financial adviser's opinion of Minsheng Securities Co., Ltd. on insider information related to Puyuan Information Technology Co., Ltd.'s termination of major asset restructuring matters and stock trading during the self-insp
  SZSI · 2021/3/24
• Freedom Capital Markets Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $97
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Oppenheimer Maintains Inspire Medical Systems(INSP.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  UBS Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $45 to $85
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $56
  \u5e02\u573a\u8d44\u8baf · 2026/7/4
• 评级变动
  Mizuho Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $55
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39
  \u5e02\u573a\u8d44\u8baf · 2026/5/22
• 评级变动
  A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $55 to $65
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  Evercore Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $55
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $85
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  Stifel Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $80
  \u5e02\u573a\u8d44\u8baf · 2026/9/11

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。